XTX Topco’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$229K Buy
+14,096
New +$243K ﹤0.01% 3021
2024
Q2
– Sell
-8,774
Closed -$311K – 2132
2024
Q1
$311K Buy
+8,774
New +$351K 0.04% 823
2023
Q3
– Sell
-10,965
Closed -$451K – 1760
2023
Q2
$451K Buy
+10,965
New +$528K 0.08% 435
2022
Q2
– Sell
-3,861
Closed -$248K – 963
2022
Q1
$248K Buy
+3,861
New +$254K 0.11% 333
2021
Q4
– Sell
-3,175
Closed -$217K – 831
2021
Q3
$217K Buy
+3,175
New +$224K 0.07% 470
2021
Q2
– Sell
-4,044
Closed -$279K – 936
2021
Q1
$279K Buy
+4,044
New +$274K 0.14% 304

Other funds holding IART

XTX Topco's IART Position: Q3 2026 in Review

XTX Topco opened a new position in Integra LifeSciences (IART) in Q3 2026: 14,096 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #3021 among its holdings. This is a return to the name: XTX Topco previously reported a position in IART as recently as Q1 2024.

XTX Topco first reported a position in IART in Q1 2021 and has held it in 6 quarters since. The position peaked at $451K in Q2 2023. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • XTX Topco held 14,096 shares of Integra LifeSciences worth $229K as of Q3 2026.
  • Integra LifeSciences was a new XTX Topco position in Q3 2026.
  • Integra LifeSciences made up ﹤0.01% of XTX Topco's portfolio in Q3 2026, its #3021 holding.
  • XTX Topco first reported a position in Integra LifeSciences in Q1 2021 and has held it in 6 quarters since.
  • XTX Topco's Integra LifeSciences position peaked at $451K in Q2 2023.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.